ERBB2 and breast carcinoma: We further analyzed the mRNA expression of TMSB10 in the breast cancer tissue samples of TCGA different molecular subtypes, which contribute to the significant heterogeneity of breast cancer and found that compared with normal tissues, TMSB10 was differentially upregulated in all subtypes except the luminal A subtype, and was strikingly higher in the basal-like and human epidermal growth factor receptor 2 (Her2)-enriched subtypes (Additional file 3: Figure S1c and d).